← FDA DRUG APPROVALS

FDA NDA · NDA017518

YTTERBIUM YB 169 DTPA

Sponsor: 3M

APPLICATION
NDA017518
TYPE
NDA
ORIGINAL APPROVAL
1976-03-11
LATEST ACTION
1985-03-05
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

YTTERBIUM YB 169 DTPADiscontinued
PENTETATE CALCIUM TRISODIUM YB-169 2mCi/ML · INJECTABLE · INJECTION

Approval history

1985-03-05Labeling · Supplement 2 · priorityAP
1976-09-23Labeling · Supplement 1 · priorityAP
1976-03-11Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →